Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The company's strong cash flow supports continued dividend growth and business ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Trading at just 11 times forward earnings ... as depicted by the moving average convergence divergence and signal line chart. Pfizer's MACD line vs. Signal line Starting from early May, the ...

Guggenheim finds itself in the middle of a battle between Pfizer and Starboard Value as ... Selling the news is a common trading strategy in which traders buy a stock in anticipation of expected ...

Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...

Pfizer stock (NYSE: PFE) is trading at about $30 per share ... Pfizer’s sales have seen a v-top chart pattern lately. Pfizer’s revenues surged from $41.7 billion in 2020 to $100.3 billion ...